Cargando…

Rapid progression of colonic mucinous adenocarcinoma with immunosuppressive condition: A case report and review of literature

BACKGROUND: Colorectal mucinous adenocarcinoma is a rare subtype of colorectal cancer and is characterized by an abundance of mucin in the tumor. In addition, the colorectal mucinous adenocarcinoma often demonstrates poor differentiation in the histology of tumor cells and poor prognosis compared wi...

Descripción completa

Detalles Bibliográficos
Autores principales: Koseki, Youhei, Kamimura, Kenya, Tanaka, Yuto, Ohkoshi-Yamada, Marina, Zhou, Qiliang, Matsumoto, Yoshifumi, Mizusawa, Takeshi, Sato, Hiroki, Sakamaki, Akira, Umezu, Hajime, Yokoyama, Junji, Terai, Shuji
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Baishideng Publishing Group Inc 2021
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8567511/
https://www.ncbi.nlm.nih.gov/pubmed/34786403
http://dx.doi.org/10.12998/wjcc.v9.i30.9182
Descripción
Sumario:BACKGROUND: Colorectal mucinous adenocarcinoma is a rare subtype of colorectal cancer and is characterized by an abundance of mucin in the tumor. In addition, the colorectal mucinous adenocarcinoma often demonstrates poor differentiation in the histology of tumor cells and poor prognosis compared with those with adenocarcinoma. Here, we present the case of a young woman with colonic mucinous adenocarcinoma showing significantly rapid progression within four months of immunosuppressant therapy for Henoch–Schönlein purpura. CASE SUMMARY: Here we report a rare case of ascending colon mucinous adenocarcinoma with lymph node and liver metastases which developed and progressed rapidly within four months during the treatment of Henoch–Schönlein purpura using corticosteroids. The systemic screening examinations showed no tumors before the immunosuppressant therapy. Fortunately, the patient was successfully treated with chemotherapy. CONCLUSION: While no direct evidence that the immunosuppressants accelerated the tumor development, the case presenta tion and review of the literature demonstrated that surveillance for malignancies before and during treatment with immunosuppressive agents is essential.